UTMD vs. CERS, OSUR, ANIK, WST, COO, ALGN, MMSI, HAE, ICUI, and XRAY
Should you be buying Utah Medical Products stock or one of its competitors? The main competitors of Utah Medical Products include Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry.
Utah Medical Products vs.
Utah Medical Products (NASDAQ:UTMD) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.
Cerus has a consensus price target of $3.63, indicating a potential upside of 102.51%. Given Cerus' stronger consensus rating and higher probable upside, analysts clearly believe Cerus is more favorable than Utah Medical Products.
Utah Medical Products has a beta of 0.09, meaning that its share price is 91% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500.
Utah Medical Products has a net margin of 34.62% compared to Cerus' net margin of -11.19%. Utah Medical Products' return on equity of 12.10% beat Cerus' return on equity.
Cerus received 415 more outperform votes than Utah Medical Products when rated by MarketBeat users. Likewise, 72.30% of users gave Cerus an outperform vote while only 61.60% of users gave Utah Medical Products an outperform vote.
Utah Medical Products has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.
69.6% of Utah Medical Products shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 6.6% of Utah Medical Products shares are held by company insiders. Comparatively, 3.4% of Cerus shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Cerus had 3 more articles in the media than Utah Medical Products. MarketBeat recorded 4 mentions for Cerus and 1 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 1.76 beat Cerus' score of 0.24 indicating that Utah Medical Products is being referred to more favorably in the media.
Summary
Utah Medical Products and Cerus tied by winning 9 of the 18 factors compared between the two stocks.
Get Utah Medical Products News Delivered to You Automatically
Sign up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Utah Medical Products Competitors List
Related Companies and Tools
This page (NASDAQ:UTMD) was last updated on 1/21/2025 by MarketBeat.com Staff
